Brief: Biofrontera Inc Announces Pricing Of $9.4 Million Private Placement
16/05/2022 13:18
May 16 (Reuters) - Biofrontera Inc BFRI.O :
* . ANNOUNCES PRICING OF $9.4 MILLION PRIVATE PLACEMENT
* SAYS PURCHASE PRICE FOR ONE SHARE OF COMMON STOCK AND A
WARRANT
TO PURCHASE ONE SHARE OF COMMON STOCK IS $2.75
Source text for Eikon: ID:nGNX51J1Kn
Further company coverage: BFRI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biofrontera
See all newsBrief: Biofrontera Submits Supplemental New Drug Application To FDA To Expand Ameluz® Red Light Pdt To Actinic Keratoses On The Full Body
Biofrontera Inc reports results for the quarter ended June 30 - Earnings Summary
Biofrontera Q2 revenue rises on higher volume, pricing
Biofrontera Inc expected to post a loss of 10 cents a share - Earnings Preview
Biofrontera Q1 revenue rises on higher Ameluz sales